Developing Transformative Therapies for High-Value Inflammatory Diseases
RAPT Therapeutics is strategically focused on developing ozureprubart (RPT904), a next-generation omalizumab bio-better anti-IgE antibody designed for high-value inflammatory diseases.
Dentsply Sirona Renews U.S. Dental Technology Distribution Partnership with Patterson Dental
Dentsply Sirona and Patterson Dental have renewed their U.S. dental technology distribution agreement to accelerate growth and expand access to high-quality dental technology solutions.
United Community Banks, Inc. Reports Fourth Quarter Earnings with Margin Expansion
United Community Banks, Inc. reported net income of $86.5 million for Q4 2025 and annual net income of $328 million for 2025.
AngioDynamics at J.P. Morgan 44th Annual Healthcare Conference: Driving Growth and Profitability
AngioDynamics participated in the J.P. Morgan 44th Annual Healthcare Conference on January 14, 2026, showcasing its strategic direction and financial performance.
Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026
Incannex Healthcare Inc. highlights its substantial clinical, regulatory, and financial progress in 2025 and outlines its well-funded outlook for 2026, setting the stage for transformative growth and value creation.
Entegris Declares Quarterly Cash Dividend
Entegris, Inc. announced a quarterly cash dividend of $0.10 per share.
C4 Therapeutics Outlines Strategic Milestones for Advancing Cemsidomide
C4 Therapeutics, a clinical-stage biopharmaceutical company, detailed strategic milestones through 2028.
Flutter Entertainment plc Appoints David Kenny as Independent Non-Executive Director
Flutter Entertainment plc announces the appointment of David Kenny as a non-executive director.
Horizon Aircraft Provides Business Update and Second Quarter of Fiscal 2026 Results
Horizon Aircraft reported financial and operational results for the second quarter of fiscal 2026, showcasing notable advancements in their strategic initiatives.
Redefining Oncology Treatment with Next-Generation Radiopharmaceuticals
Catamaran Bio is revolutionizing oncology treatment with their next-generation radiopharmaceuticals, leveraging innovative technology and a diverse portfolio.
The Coca-Cola Company Announces Changes in Operational Leadership and Creation of New Enterprise Role to Accelerate Digital Transformation
The Coca-Cola Company announced a series of leadership changes to enhance consumer focus and accelerate technology adoption.
Labcorp Declares Quarterly Dividend
Labcorp Holdings Inc. (NYSE: LH) declared a cash dividend of $0.72 per share of common stock.
Bank of America Reports Strong Financial Performance in 4Q25
Bank of America's 4Q25 financial highlights include net income of $7.6 billion and revenue of $28.4 billion, up 7% year-over-year.
Magnachip Announces the Retirement of Director Ilbok Lee
Magnachip Semiconductor Corporation announced the retirement of Director Ilbok Lee from the Company's Board of Directors.
Nuvalent Announces OnTarget 2026 Operating Plan Progress and Key Milestones
Nuvalent detailed its 2026 operating plan progress and key anticipated milestones for the year, focusing on advancing its innovative therapies in the NSCLC treatment space.
Wells Fargo Reports Strong Fourth Quarter 2025 Results
Wells Fargo reported a net income of $5.4 billion, or $1.62 per diluted share for the fourth quarter of 2025.
Palladyne AI Update: Preliminary Financials and Future Outlook
Palladyne AI's update includes forward-looking statements on preliminary unaudited revenue for 2025 and estimated cash burn for 2026, signaling the company's financial performance expectations and capital management strategy.
Fifth Third and Comerica Announce Receipt of All Material Approvals to Combine
Fifth Third Bancorp (Nasdaq: FITB) and Comerica Incorporated (NYSE: CMA) have received all material approvals to merge, forming the ninth largest U.S. bank with $290 billion in assets.
Playtika Announces Workforce Reduction for Future Investment
Playtika is reducing its workforce by approximately 15% to reallocate resources for future growth and competitiveness in the mobile games market.
Analyzing SemiLEDs Corporation's Q1 FY2026 Financial Performance
SemiLEDs Corporation has released its financial results for the first quarter of fiscal year 2026, revealing key insights into its operational performance and financial health.
AITX Files Q3 FY 2026 10-Q Early with CEO Interview and Investor Q&A
Artificial Intelligence Technology Solutions, Inc. (AITX) is filing its Quarterly Report on Form 10-Q for the third quarter of fiscal year 2026 ahead of schedule on January 14, 2026. This proactive move indicates a strategic intent to enhance investor communication and transparency, setting the stage for a deeper engagement.
Provident Bank CFO Tom Lyons to Retire After Long, Successful Career
Provident Bank announced the planned retirement of Thomas M. Lyons, Senior Executive Vice President and CFO. Mr. Lyons will continue in his roles until a successor is appointed. A nationwide search for his replacement has been initiated.
Jefferies Financial Group Inc. Announces Pricing of $1,500,000,000 5.500% Senior Notes Due 2036
Jefferies Financial Group Inc. announced the pricing of $1.5 billion aggregate principal amount of 5.500% Senior Notes due 2036.
Fifth Third and Comerica to Merge After Receiving Regulatory Approvals
The merger between Fifth Third Bancorp (Nasdaq: FITB) and Comerica Incorporated (NYSE: CMA) has successfully navigated the intricacies of regulatory and shareholder approvals, setting the stage for a transformative consolidation in the U.S. banking sector.
News Corporation Announces Buy-Back Program
News Corporation has announced a buy-back program for its Class A and Class B common stock.
Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds
Arcadia Biosciences announced the immediate exercise of certain outstanding preferred investment options.
Leading the Next Chapter at Avanos Medical: Insights from JP Morgan Healthcare Conference 2026
Avanos Medical, Inc. shared insights at the JP Morgan Healthcare Conference 2026 regarding their future plans and performance expectations.
The Chefs' Warehouse Announces Preliminary Fiscal Year 2026 Guidance
The Chefs' Warehouse, Inc. (NASDAQ: CHEF) provided its preliminary outlook for fiscal year 2026.
Analyzing the Strategic Significance of Student Loan Pool Composition Owned by SLM Corporation
SLM Corporation's trust student loans are a strategic selection from a consolidation loan portfolio, carefully chosen based on specific criteria.
ABC Corp Reports Record Revenue Growth in 2021
ABC Corp, a leading tech company, showcased an impressive performance in its latest annual filing, with a notable surge in revenue for the fiscal year 2021.
AirJoule Technologies Announces Proposed Public Offering of Class A Common Stock
AirJoule Technologies Corporation announced a public offering of its Class A common stock.
Belden Announces €450 Million Private Offering of Senior Subordinated Notes
Belden Inc. intends to offer €450 million in aggregate principal amount of senior subordinated notes due 2033 for sale in a private offering.
Energy Transfer LP Announces Pricing of $3.0 Billion of Senior Notes
Energy Transfer LP announced the pricing of $3.0 billion senior notes offering.
Stabilization and Growth Trends in the RV Industry
The RV industry has experienced a notable stabilization trend with a positive inflection since June, signaling potential growth ahead.
Cineverse Acquires Giant Worldwide and Integrates Service into Matchpoint™ Platform, Solidifying Leadership in Media Services
Cineverse recently completed the acquisition of Giant Worldwide, a prominent global media services provider catering to top-tier Hollywood studios and streaming platforms. This move signifies a strategic step towards enhancing Cineverse's position in the media services industry.
Innovation Impact in Endocrinology: Insights from J.P. Morgan Healthcare Conference
Crinetics Pharmaceuticals presents forward-looking statements at J.P. Morgan Healthcare Conference, highlighting their strategic initiatives and drug candidates.
Analysis of Trust Student Loan Pool by SLM Corporation
SLM Corporation provides a detailed breakdown of the trust student loans held within the trust structure, derived from a consolidation of student loans.
Shareholders Approve Acquisition by IES Holdings
Gulf Island Fabrication, Inc.'s shareholders have approved the acquisition by IES Holdings, Inc.
Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
Guardian Pharmacy Services, a leading long-term care pharmacy services company, reaffirms its 2025 guidance and offers a glimpse into its financial outlook for 2026.
Kaiser Aluminum Corporation Announces Quarterly Dividend Payment
Kaiser Aluminum Corporation declared a quarterly cash dividend of $0.77 per share.
Clene Announces Registered Direct Offering of Over $28 Million
Clene, a late clinical-stage biopharmaceutical company, announced a registered direct offering of over $28 million.
Peak Exploration & Production Reports Financial Performance for Q3 2025
Peak Exploration & Production, LLC and its subsidiaries released their condensed consolidated financial statements for the third quarter of 2025.
Advance Auto Parts Appoints Richard A. Johnson to Board of Directors
Advance Auto Parts, Inc. appoints Richard "Dick" A. Johnson as an independent director to the Board of Directors.
Victory Capital Reports December 2025 Total Client Assets and Fourth-Quarter Financial Results
Victory Capital Holdings, Inc. reported Total Assets Under Management (AUM) of $313.8 billion, Other Assets of $2.8 billion, and Total Client Assets of $316.6 billion as of December 31, 2025.
TG Therapeutics Provides Preliminary Revenue Figures and 2026 Guidance
TG Therapeutics announced impressive preliminary revenue figures for 2025 and provided guidance for 2026 during the 44th Annual J.P. Morgan Healthcare Conference.
P&G Declares Quarterly Dividend, January 2026
The Board of Directors of The Procter & Gamble Company declared a quarterly dividend of $1.0568 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock.
Latch (Now DOOR) Files Q1 2025 SEC Report and Provides Financial Update
Latch, Inc., now known as DOOR, filed its Quarterly Report on Form 10-Q for the three months ended March 31, 2025, with the SEC, marking progress towards regaining current reporting status.
Grocery Outlet Holding Corp. Announces Chief Purchasing Officer Retirement
Grocery Outlet Holding Corp. announced the retirement of Steve Wilson, EVP and Chief Purchasing Officer, effective March 20, 2026, after 31 years of service.
Impinj Announces Preliminary Fourth-Quarter 2025 Revenue and Adjusted EBITDA
Impinj, Inc. (Nasdaq: PI) anticipates fourth-quarter 2025 revenue to be near the high end of the guidance, around $90.0 to $93.0 million.
Target Hospitality Appoints Chief Accounting Officer
Target Hospitality, a leading provider of specialty rental accommodations, has announced the appointment of Cyril J. Hahamski as its new Chief Accounting Officer.
Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
Rapid Micro Biosystems anticipates a remarkable fourth quarter 2025 revenue of $11.3 million, reflecting a substantial 37% increase from the previous year. The full-year 2025 revenue is expected to reach approximately $33.6 million, demonstrating a notable 20% growth compared to the prior year. The Company's revenue growth is driven by robust performance in recurring revenue streams, accompanied by record-setting achievements in system placements and customer validations.
Boost Run Inc. Amends Earnout Agreement: Key Details and Implications
Boost Run Inc. made amendments to the Earnout Agreement with Willow Lane Sponsor, LLC and SPV on January 13, 2026.
Array Completes Sale of Spectrum Assets to AT&T for $1.018 Billion and Declares Special Dividend
Array Digital Infrastructure, Inc. completed the sale of select spectrum assets to AT&T for $1.018 billion, strategically monetizing assets not part of previous sales.
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results
Cytek Biosciences announces preliminary unaudited revenue results for Q4 and full year 2025, expecting total revenue of $201 million for 2025.
Precision BioSciences Sets Strategic Priorities for 2026, Highlights Clinical Programs
Precision BioSciences recently unveiled its strategic priorities for 2026, placing a significant emphasis on advancing its clinical programs PBGENE-HBV and PBGENE-DMD.
Concrete Pumping Holdings Reports Fourth Quarter and Fiscal Year 2025 Results
Concrete Pumping Holdings, a leading provider of concrete pumping and waste management services, reported its financial results for the fourth quarter and fiscal year 2025.
Rocky Mountain Chocolate Factory Reports Third Quarter Fiscal 2026 Financial Results
Rocky Mountain Chocolate Factory, Inc. announced their financial and operating results for the third quarter of fiscal 2026, showcasing a strategic shift towards profitability and growth.
Solitron Devices, Inc. Announces Fiscal 2026 Third Quarter Results
Solitron Devices, Inc. announced their fiscal 2026 third quarter results with significant improvements in key financial metrics.
Tamboran Appoints Todd Abbott as CEO: A Strategic Move for Growth
Tamboran Resources Corporation appoints Todd Abbott as the new Chief Executive Officer, effective January 15, 2026.
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
Glaukos Corporation reported its preliminary, unaudited net sales for the fourth quarter and full year of 2025, showing significant growth compared to the previous year. This growth underscores the company's effective commercial strategies and product development efforts, positioning it for sustained expansion in the competitive ophthalmic sector.